Innovent and NeoCura Announce Strategic Collaboration to Study the Combination Therapy of Sintilimab and Neoantigen Vaccine NEO PLIN2101 for Cancer Treatment in China - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high.
NeoCura Bio-Medical Technology Co., Ltd, a leading AI-enabled RNA precision medicine company based on research, development and MDimune Inc., a leading extracellular vesicle (EV)-based drug delivery platform company, has announced the signing of collaboration focused on mRNA delivery for oncological therapeutics.